For individuals living with chronic conditions, only a small fraction of their time involves direct interaction with healthcare providers, leaving them to manage their conditions independently for the majority of their time. This underscores the critical need for digital health solutions that can support patients throughout their treatment journey, from diagnosis and treatment selection to adherence and ongoing condition management.
This whitepaper explores the growing importance of device-enabled digital health solutions in transforming chronic disease management and supporting patient self-care.
Despite past challenges and varying levels of success in developing these solutions, pharma companies continue to invest in them with sustained efforts in developing device-enabled digital health solutions presenting significant opportunities across the drug lifecycle, offering the potential to transform chronic disease management and improve patient self-care
The whitepaper explores the lessons learned by the industry, emphasizing the importance of managing expectations, gaining internal alignment, and maintaining focus on core challenges. A new approach, leveraging pre-proven device connectivity and a platform-based framework, is enabling faster and more efficient development of digital health solutions. This shift allows pharma companies to concentrate on defining value propositions, creating robust business models, and ensuring alignment with long-term goals.
Download the full paper today and read insights from experts from S3 Connected Health, Ypsomed, Roche, and ViiV Healthcare on areas including:
File Size: 2.5 MB